Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000944208 | SCV001090173 | benign | not provided | 2024-02-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434302 | SCV002751618 | likely benign | Cardiovascular phenotype | 2022-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001272628 | SCV001454751 | uncertain significance | Hyperlipoproteinemia, type I | 2019-12-18 | no assertion criteria provided | clinical testing |